Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees
13/05/2025 13:12
May 13 (Reuters) - Suven Life Sciences Ltd SUVP.NS: SUVEN LIFE SCIENCES MARCH-QUARTER CONSOL NET LOSS 439.4 MILLION RUPEES Source text: ID:nBSE6GJwxn Further company coverage: SUVP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees